412 related articles for article (PubMed ID: 28353057)
41. Comparison of Plasma, Saliva, and Hair Levetiracetam Concentrations.
Karaś-Ruszczyk K; Kuczyńska J; Sienkiewicz-Jarosz H; Kurkowska-Jastrzębska I; Bienkowski P; Restel M; Samochowiec J; Mierzejewski P
Ther Drug Monit; 2017 Jun; 39(3):263-268. PubMed ID: 28490049
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and tolerability of levetiracetam for pediatric refractory epilepsy.
Muramatsu K; Sawaura N; Ogata T; Makioka N; Tomita K; Motojima T; Ida K; Hazama K; Arakawa H
Brain Dev; 2017 Mar; 39(3):231-235. PubMed ID: 27745925
[TBL] [Abstract][Full Text] [Related]
43. Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy.
Freitas-Lima P; Alexandre V; Pereira LR; Feletti F; Perucca E; Sakamoto AC
Epilepsy Res; 2011 Mar; 94(1-2):117-20. PubMed ID: 21282041
[TBL] [Abstract][Full Text] [Related]
44. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
[TBL] [Abstract][Full Text] [Related]
45. Population pharmacokinetics of levetiracetam in Japanese and Western adults.
Pigeolet E; Jacqmin P; Sargentini-Maier ML; Stockis A
Clin Pharmacokinet; 2007; 46(6):503-12. PubMed ID: 17518509
[TBL] [Abstract][Full Text] [Related]
46. Population Pharmacokinetic Modeling of Levetiracetam in Pediatric and Adult Patients With Epilepsy by Using Routinely Monitored Data.
Ito S; Yano I; Hashi S; Tsuda M; Sugimoto M; Yonezawa A; Ikeda A; Matsubara K
Ther Drug Monit; 2016 Jun; 38(3):371-8. PubMed ID: 26913593
[TBL] [Abstract][Full Text] [Related]
47. Levetiracetam: a new therapeutic option for refractory epilepsy.
Pinto A; Sander JW
Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics of levetiracetam.
Radtke RA
Epilepsia; 2001; 42 Suppl 4():24-7. PubMed ID: 11564121
[TBL] [Abstract][Full Text] [Related]
49. Meta-analysis of randomized trials on first line and adjunctive levetiracetam.
Lo BW; Kyu HH; Jichici D; Upton AM; Akl EA; Meade MO
Can J Neurol Sci; 2011 May; 38(3):475-86. PubMed ID: 21515509
[TBL] [Abstract][Full Text] [Related]
50. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
51. Update on Antiepileptic Drugs 2019.
Abou-Khalil BW
Continuum (Minneap Minn); 2019 Apr; 25(2):508-536. PubMed ID: 30921021
[TBL] [Abstract][Full Text] [Related]
52. Levetiracetam for managing neurologic and psychiatric disorders.
Farooq MU; Bhatt A; Majid A; Gupta R; Khasnis A; Kassab MY
Am J Health Syst Pharm; 2009 Mar; 66(6):541-61. PubMed ID: 19265183
[TBL] [Abstract][Full Text] [Related]
53. Intravenous levetiracetam in children with seizures: a prospective safety study.
Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
[TBL] [Abstract][Full Text] [Related]
54. Retrospective study of the use of levetiracetam in childhood seizure disorders.
Koukkari MW; Guarino EJ
J Child Neurol; 2004 Dec; 19(12):944-7. PubMed ID: 15704867
[TBL] [Abstract][Full Text] [Related]
55. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
Muñana KR; Nettifee-Osborne JA; Papich MG
J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
[TBL] [Abstract][Full Text] [Related]
56. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
[TBL] [Abstract][Full Text] [Related]
57. Levetiracetam: preliminary efficacy in generalized seizures.
Kasteleijn-Nolst Trenité DG; Hirsch E
Epileptic Disord; 2003 May; 5 Suppl 1():S39-44. PubMed ID: 12915340
[TBL] [Abstract][Full Text] [Related]
58. Pharmacokinetic study of levetiracetam in children.
Pellock JM; Glauser TA; Bebin EM; Fountain NB; Ritter FJ; Coupez RM; Shields WD
Epilepsia; 2001 Dec; 42(12):1574-9. PubMed ID: 11879369
[TBL] [Abstract][Full Text] [Related]
59. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
Dooley M; Plosker GL
Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
[TBL] [Abstract][Full Text] [Related]
60. The treatment of neonatal seizures: focus on Levetiracetam.
Loiacono G; Masci M; Zaccara G; Verrotti A
J Matern Fetal Neonatal Med; 2016; 29(1):69-74. PubMed ID: 25385270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
